Angelini Pharma, Lumira Ventures unveil biosciences fund

Angelini Pharma and Lumira Ventures have launched the Angelini Lumira Biosciences Fund with a $35 million commitment from Angelini.

28 July 2021•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles